BERNARD ZOVIGHIAN
CEO
EDWARDS LIFESCIENCES
WHY: Last year took over the top spot at Orange County’s most valuable medical device maker from Mike Mussallem, the only CEO the heart valve company has known since going public in 2000.
IN THE NEWS: In June, announced that company would sell its Critical Care unit for $4.2B rather than spin it out.
NOTABLE: Previously headed smallest but fastest-growing unit, Transcatheter Mitral and Triscupid Therapies, which doubled sales to $86M in 2021 and another nearly 50% to $116M in 2022.
QUOTABLE: “Edwards’ underlying rationale for separating Critical Care remains the same: we are laser focused on pursuing a strategy centered on structural heart disease.”
